(Q44412169)

2 December 2017

Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy (English)

1 reference

2 December 2017

endometrial carcinoma

1 reference

3

Takeshi Kuwata

1 reference

2 December 2017

Makoto Saegusa

1

1 reference

2 December 2017

Mieko Hamano

2

1 reference

2 December 2017

Tsutomu Yoshida

4

1 reference

2 December 2017

Miki Hashimura

5

1 reference

2 December 2017

Fumiyuki Akino

6

1 reference

2 December 2017

Jun Watanabe

7

1 reference

2 December 2017

Hiroyuki Kuramoto

8

1 reference

2 December 2017

Isao Okayasu

9

1 reference

2 December 2017

language of work or name

1 reference

1 January 2003

1 reference

2 December 2017

1 reference

2 December 2017

94

1 reference

2 December 2017

1

1 reference

2 December 2017

103-111

1 reference

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

2 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

The adenomatous polyposis coli (APC) tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Significance of sex steroids in roles of cadherin subfamily and its related proteins in the uterine endometrium and placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Targeting human tumours with antigen-specific cytotoxic T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Mutations of the beta-catenin gene in endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

Age-dependent differences in tumor cell polarity in endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01360.X

10.1111/J.1349-7006.2003.TB01360.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference